Vanguard Group Inc. Acquires 17,805 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Vanguard Group Inc. lifted its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 0.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,682,065 shares of the medical instruments supplier’s stock after purchasing an additional 17,805 shares during the period. Vanguard Group Inc. owned about 10.96% of ICU Medical worth $416,176,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ICUI. Harvest Fund Management Co. Ltd purchased a new stake in ICU Medical in the 4th quarter valued at about $33,000. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical during the third quarter valued at approximately $72,000. Venturi Wealth Management LLC boosted its holdings in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 206 shares during the period. Smartleaf Asset Management LLC grew its stake in ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock worth $140,000 after purchasing an additional 567 shares in the last quarter. Finally, Coldstream Capital Management Inc. purchased a new position in ICU Medical during the 3rd quarter worth $227,000. 96.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ICUI. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, December 11th. Finally, StockNews.com cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, March 27th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $168.67.

ICU Medical Trading Up 1.9 %

Shares of NASDAQ:ICUI opened at $140.38 on Thursday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.44 billion, a PE ratio of -30.72 and a beta of 0.73. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The business’s fifty day simple moving average is $152.81 and its 200-day simple moving average is $163.08.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.